Close Menu

NEW YORK (GenomeWeb) – MDxHealth reported today that its first quarter revenues dropped 51 percent year over year due to the organizational changes during the transitory period.

For the three months ended March 31, the molecular diagnostics company's revenues fell to $4.7 million from $9.7 million in Q1 2018.

MDxHealth reported an operating loss of $8.6 million for the quarter, up 28 percent from $6.7 million a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.